ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

E-CYPRO

Product Packing: 100 ML

Product Composition: Cyproheptidine + Tricholine citrate

Product Price: MRP : 89

E-CYPRO

Cyproheptadine + Tricholine Citrate | SYP 100 ML

E-CYPRO is an oral syrup containing Cyproheptadine with Tricholine Citrate. Cyproheptadine is a first-generation antihistamine with antiserotonergic and anticholinergic properties, while Tricholine Citrate is a choline-source compound used in selected formulations. Use should follow the current approved product label and healthcare professional guidance.

Cyproheptadine blocks histamine H1 and serotonin receptors and can cause sedation and increased appetite in some patients. Tricholine Citrate provides a choline-related component used in some formulations positioned for lipotropic and digestive support. Exact ingredient strengths and concentration per measured dose must be confirmed from the current approved product label.

Composition

Each labelled dose contains:

·         Cyproheptadine - as per approved product specification

·         Tricholine Citrate - as per approved product specification

·         Syrup base / excipients - q.s. The supplied brief does not provide individual strengths or a per-volume basis; these details must be verified from the approved product label.

Dosage form: Oral Syrup

Pack size: 100 ml

Uses of E-CYPRO

E-CYPRO should be used only for approved indications and according to professional guidance. Product-specific use depends on the exact formulation, strength, patient age and current approved label.

·         Cyproheptadine provides H1-antihistamine activity for selected allergic conditions where approved

·         Its antiserotonergic action and appetite-stimulating effect may be clinically relevant in selected patients only when specifically prescribed or approved

·         Tricholine Citrate provides a choline-related component used in selected digestive/lipotropic-support formulations

·         Use should be individualized; it should not be promoted as a general-purpose weight-gain or appetite product without approved indication and professional assessment

Persistent loss of appetite, unexplained weight loss, recurrent allergy symptoms or other ongoing complaints require appropriate medical evaluation.

How E-CYPRO Works

E-CYPRO combines Cyproheptadine and Tricholine Citrate:

Cyproheptadine: A first-generation H1 antihistamine with serotonin-antagonist and anticholinergic activity. These actions explain both its therapeutic effects and adverse effects such as drowsiness and dry mouth.

Tricholine Citrate: Provides a choline-related component used in some formulations positioned for lipotropic and digestive support; exact claims should follow the approved label.

Cyproheptadine may increase appetite in some patients, but this effect requires appropriate clinical context and should not replace evaluation of underlying causes of poor appetite or weight loss.

The overall effect depends on the exact strengths, dose, patient age, indication, concomitant medicines and individual response.

Symptoms should be clinically evaluated if persistent, severe, unexplained or associated with significant weight loss or other alarm features.

 

Dosage and Direction for Use

Use E-CYPRO strictly according to the approved product label or healthcare professional's prescription/advice. The supplied brief does not state individual strengths or serving volume, so no dose has been inferred in this document.

Measure the prescribed quantity accurately with a calibrated measuring cup, spoon or oral syringe as appropriate.

Cyproheptadine may cause drowsiness and impaired alertness. Avoid driving, operating machinery or other hazardous activities until its effects are known.

Children, older adults, pregnancy, breastfeeding and patients with chronic disease require age- and condition-specific professional assessment before use.

Possible Side Effects

Possible adverse effects of Cyproheptadine-containing products may include:

·         Drowsiness, dizziness, fatigue or impaired coordination

·         Dry mouth, blurred vision, constipation or urinary difficulty due to anticholinergic effects

·         Nausea or gastrointestinal discomfort

·         Increased appetite and weight gain may occur in some patients; paradoxical excitation can occur, particularly in children

·         Seek urgent medical attention for severe allergic reaction, marked confusion, breathing difficulty, severe urinary retention, significant visual symptoms or other serious reactions.

Any persistent or troublesome adverse effect should be discussed with a healthcare professional.

Precautions and Contraindications

·         Review the complete approved label before use, particularly in children, older adults and patients taking medicines that cause sedation or have anticholinergic effects.

·         Avoid use in patients with known hypersensitivity to Cyproheptadine, Tricholine Citrate or any formulation excipient.

·         Cyproheptadine requires caution or may be contraindicated in conditions such as angle-closure glaucoma, urinary retention/prostatic obstruction, gastrointestinal obstruction or other situations where anticholinergic effects may be harmful; verify the approved label.

·         Avoid alcohol and use caution with sedatives, sleeping medicines, opioids and other CNS depressants because drowsiness and impairment can be increased.

·         Monoamine oxidase inhibitors (MAOIs) can intensify or prolong anticholinergic effects of antihistamines; current label guidance and washout requirements must be followed.

·         Use in pregnancy, breastfeeding, infants and young children requires specific approved-label and professional review.

·         Check sweeteners, flavours, preservatives and potential allergens on the final approved label.

·         Keep out of reach of children and store according to the approved pack instructions.

·         Drug Interaction Considerations

·         Cyproheptadine can have additive effects with alcohol, sedatives, opioids, anxiolytics, sleep medicines and other CNS depressants. MAOIs and medicines with anticholinergic properties may increase adverse effects. Review the complete medication list before use.

·         Provide the healthcare professional with a complete list of prescription medicines, OTC antihistamines/cold medicines, herbal products and supplements before regular use.

Business Growth Opportunity with E-CYPRO

E-CYPRO offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Cyproheptadine + Tricholine Citrate oral syrup in a convenient 200 ml pack to their prescription and supportive-care portfolio, subject to approved indications and applicable regulations.

Promotion must remain consistent with the final approved composition, prescription status, permitted claims, ethical pharmaceutical practice and applicable regulations. Appetite or weight-related promotion should not exceed approved indications.

 

Key Business Advantages

·         Cyproheptadine + Tricholine Citrate combination

·         Antihistamine-based prescription/supportive-care formulation

·         Convenient oral syrup dosage form

·         200 ml pack

·         Suitable addition to relevant prescription portfolios subject to approved formulation and indications

·         Opportunity for ethical promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for E-CYPRO

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for E-CYPRO in selected territories across India, subject to availability, prescription/regulatory requirements and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids consistent with approved claims

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for E-CYPRO and other quality-focused healthcare products.

Third-Party Manufacturing Support for Cyproheptadine + Tricholine Citrate Syrup

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to E-CYPRO under their own brand, subject to applicable drug licensing, prescription-status, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized approved strengths and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed oral-syrup portfolio.

Frequently Asked Questions About E-CYPRO

1. What is E-CYPRO?

E-CYPRO is a 200 ml oral syrup containing Cyproheptadine and Tricholine Citrate according to the supplied product brief.

2. What is Cyproheptadine?

Cyproheptadine is a first-generation antihistamine with antiserotonergic and anticholinergic properties. It can cause drowsiness and may increase appetite in some patients.

3. What is Tricholine Citrate?

Tricholine Citrate is a choline-source compound used in selected formulations. Product-specific claims should follow the approved label.

4. Can E-CYPRO be used to increase appetite?

Cyproheptadine can increase appetite in some patients, but use for appetite-related purposes should only follow the approved indication and professional assessment, particularly when poor appetite or weight loss is unexplained.

5. Can E-CYPRO cause drowsiness?

Yes. Cyproheptadine can cause drowsiness, dizziness and impaired alertness. Alcohol and other sedating medicines can increase these effects.

6. How should E-CYPRO be taken?

Follow the approved label or healthcare professional's directions and measure the prescribed serving accurately. The supplied brief does not provide individual strengths or a serving volume.

7. Is a PCD Pharma Franchise available for E-CYPRO?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Cyproheptadine + Tricholine Citrate syrup may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable drug licensing and regulatory requirements.

Disclaimer

E-CYPRO product information in this document is for general professional and business information. The supplied product brief states Cyproheptidine + Tricholine Citrate, SYP 200 ML; the medicine name has been standardized here as Cyproheptadine. The brief does not provide individual strengths or measured serving volume, so these details have not been inferred. Exact composition, concentration per measured dose, approved age range, prescription/regulatory status, indications, dosage, contraindications, warnings, interactions, excipients and storage requirements must be verified against the current approved product label before manufacture, promotion, recommending, dispensing or use. Cyproheptadine may cause sedation and anticholinergic adverse effects. Persistent poor appetite, unexplained weight loss or recurrent symptoms require appropriate clinical assessment. This document is not a substitute for professional medical advice.

Contact